We hypothesize that amyloid Beta-protein (Abeta) assembly is a seminal neuropathogenetic process in Alzheimer's disease (AD) and in cerebral amyloid angiopathy (CAA). If so, controlling Abeta assembly could be of therapeutic value. Over the last decade, we have worked to elucidate the pathways of Abeta self-association in vitro, to identify assembly intermediates, and to evaluate the neurotoxic activities of these structures. This work led to the discovery of the amyloid protofibril, later found to be neurotoxic in vitro and in vivo, and to be linked to an """"""""Arctic"""""""" form of AD. Recently, novel chemical cross-linking studies have revealed the existence of smaller oligomeric structures (paranuclei), which are formed rapidly by Abeta (1-42) but not by Abeta (1-40). The strong association of Abeta (1-42) with AD thus may result from Abeta (1-42)-specific assembly events occurring at the earliest stage of self-association, oligomerization. We also have described a novel helix-rich oligomeric assembly intermediate. We predicted that an Asp23->Asn amino acid replacement would affect the rate of formation of this intermediate and of fibrils. Interestingly, the importance of this site has been proven in humans through the discovery of an Iowa kindred suffering from an early onset form of CAA caused by this exact substitution. In this proposal, we will examine the thermodynamics and structural biology of early Abeta assembly reactions in order to understand the fundamental factors controlling these reactions and to characterize the structures formed. In concurrent experiments, we will examine the neurotoxic activities of the Abeta assemblies to establish which may be of most relevance pathobiologically. Our studies will provide a better understanding of the mechanisms of formation and the biological activities of Abeta assemblies and of general principles of amyloid formation and protein misfolding. Our experimental plan comprises four specific aims.
Aim 1. To elucidate the thermodynamics of early Abeta assemblies and Abeta fibril formation.
Aim 2. To determine the structural features of early Abeta assemblies.
Aim 3. To determine the structure and mechanism of action of oligomeric Abeta fibrillogenesis inhibitors.
Aim 4. To determine the biological activity of early intermediates.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS044147-05
Application #
7245026
Study Section
Molecular, Cellular and Developmental Neurosciences 2 (MDCN)
Program Officer
Refolo, Lorenzo
Project Start
2003-06-01
Project End
2009-05-31
Budget Start
2007-06-01
Budget End
2009-05-31
Support Year
5
Fiscal Year
2007
Total Cost
$465,779
Indirect Cost
Name
University of California Los Angeles
Department
Neurology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Hori, Yukiko; Hashimoto, Tadafumi; Wakutani, Yosuke et al. (2007) The Tottori (D7N) and English (H6R) familial Alzheimer disease mutations accelerate Abeta fibril formation without increasing protofibril formation. J Biol Chem 282:4916-23
Yun, Sijung; Urbanc, B; Cruz, L et al. (2007) Role of electrostatic interactions in amyloid beta-protein (A beta) oligomer formation: a discrete molecular dynamics study. Biophys J 92:4064-77
Urbanc, Brigita; Cruz, Luis; Teplow, David B et al. (2006) Computer simulations of Alzheimer's amyloid beta-protein folding and assembly. Curr Alzheimer Res 3:493-504
Lomakin, Aleksey; Teplow, David B (2006) Quasielastic light scattering study of amyloid beta-protein fibril formation. Protein Pept Lett 13:247-54
Baumketner, Andrij; Bernstein, Summer L; Wyttenbach, Thomas et al. (2006) Structure of the 21-30 fragment of amyloid beta-protein. Protein Sci 15:1239-47
Teplow, David B; Lazo, Noel D; Bitan, Gal et al. (2006) Elucidating amyloid beta-protein folding and assembly: A multidisciplinary approach. Acc Chem Res 39:635-45
Baumketner, Andrij; Bernstein, Summer L; Wyttenbach, Thomas et al. (2006) Amyloid beta-protein monomer structure: a computational and experimental study. Protein Sci 15:420-8
Castillo, Uvidelio F; Strobel, Gary A; Mullenberg, Kirby et al. (2006) Munumbicins E-4 and E-5: novel broad-spectrum antibiotics from Streptomyces NRRL 3052. FEMS Microbiol Lett 255:296-300
Teplow, David B (2006) Preparation of amyloid beta-protein for structural and functional studies. Methods Enzymol 413:20-33
Maji, Samir K; Amsden, Jason J; Rothschild, Kenneth J et al. (2005) Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence. Biochemistry 44:13365-76

Showing the most recent 10 out of 18 publications